Leaderboards/Tumors and Oncological Cases

Tumors and Oncological Cases

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Cheng Wang
Sun Yat-sen University
74
2
Rita Alaggio
Bambino Gesù Children's Hospital
27

Rising Stars Papers

1
Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma
International Journal of Oral Science|2024
14 cit.
2
Histopathological Spectrum and Molecular Characterization of Liver Tumors in the Setting of Fontan-Associated Liver Disease
Cancers|2024
7 cit.
3
Melanomas and Mesenchymal Tumors Arising in Giant Congenital Melanocytic Nevi: Clinico‐Pathological and Molecular Characterization of a Case Series
Pigment Cell & Melanoma Research|2026
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Alexander Lazzaro
Boston Medical Center
99
2
Isao Nagata
Kansai Medical University
99
3
Arwa Babai
King's College London
77
4
Sabrina Rossi
Bambino Gesù Children's Hospital
50
5
Hiroki Sakuma
The University of Tokyo
36
6
Myoung Eun Choi
Ulsan College
24
7
Ali Kaya
Burdur Mehmet Akif Ersoy Üniversitesi
11

Emerging Leaders Papers

1
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells
Veterinary and Comparative Oncology|2025
2 cit.
2
Cancer of Unknown Primary: A Case Report on the Recognition of Its Clinical Entity and Standard of Care Management
Cureus|2025
1 cit.
3
Spindle Cell Lipoma in the Lower Lip: A Report of a Rare Case in Plastic Surgery
Cureus|2025
0 cit.
4
Exploring the FoxP3+ Lymphocytes and Their Correlation with VEGF in Canine Histiocytic Tumors
Journal of the Hellenic Veterinary Medical Society|2025
0 cit.
5
Spatial Transcriptome Analysis Reveals Factors Involved in Actinic Cheilosis Transformation to Squamous Cell Carcinoma of the Lip
Journal of Investigative Dermatology|2025
0 cit.
6
Disruption of SPECC1L translation initiation by intragenic deletion: novel pathogenic mechanism in Teebi-hypertelorism syndrome
npj Genomic Medicine|2025
0 cit.
7
Melanomas and Mesenchymal Tumors Arising in Giant Congenital Melanocytic Nevi: Clinico‐Pathological and Molecular Characterization of a Case Series
Pigment Cell & Melanoma Research|2026
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Jarno Drost
Oncode Institute
95
2
Ethylin Wang Jabs
Johns Hopkins University
94
3
Håkon Håkonarson
Children's Hospital of Philadelphia
93
4
Zhuan Bian
Wuhan University
90
5
Luc G.T. Morris
Memorial Sloan Kettering Cancer Center
82
6
C. Cameron Yin
The University of Texas MD Anderson Cancer Center
79
7
Rune Toftgård
Karolinska Institutet
79
8
Lisbeth Birk Møller
Glostrup Hospital
65
9
Tomoki Naoe
National Hospital Organization
63
10
Lurdes Queimado
United States Department of Veterans Affairs
63

All-Time Leaders Papers

1
Genome-Wide Analyses of Exonic Copy Number Variants in a Family-Based Study Point to Novel Autism Susceptibility Genes
PLoS Genetics|2009
435 cit.
2
Xenograft and organoid model systems in cancer research
The EMBO Journal|2019
405 cit.
3
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
Nature Communications|2020
305 cit.
4
Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease
Modern Pathology|2017
292 cit.
5
Genome-wide analyses of non-syndromic cleft lip with palate identify 14 novel loci and genetic heterogeneity
Nature Communications|2017
281 cit.
6
Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells
Cancer Science|2016
144 cit.
7
Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth
Nature Communications|2016
128 cit.
8
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions
Nature Communications|2017
112 cit.
9
Phenotypic variability in 49 cases of <i>ESCO2</i> mutations, including novel missense and codon deletion in the acetyltransferase domain, correlates with <i>ESCO2</i> expression and establishes the clinical criteria for Roberts syndrome
Journal of Medical Genetics|2009
107 cit.
10
Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence
Cell Death and Disease|2014
89 cit.

Reagents for Tumors and Oncological Cases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

LPCAT1 (E4V4B) Rabbit Monoclonal Antibody (BSA and Azide Free)

#81677$865
View Evidence →Cell Signaling Technology

Cleaved Caspase-8 (Asp387) (D5B2) Rabbit Monoclonal Antibody (PE Conjugate)

#14071$493
View Evidence →Cell Signaling Technology

SynGAP (D20C7) Rabbit Monoclonal Antibody

#5539$159
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

IFN-gamma (D3H2) Rabbit Monoclonal Antibody

#8455$175
View Evidence →Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

#A4502
View Evidence →Agilent/Dako

Cytokeratin 7

#M7018
View Evidence →